Volume XXXI, No. 8 – June 10, 2024
Table of Contents
Articles
ACLA Files Court Challenge to FDA’s Final LDT Rule
ACLA President Van Meter Discusses LDT Lawsuit
Attorneys Assess Impact of FDA’s Final LDT Rule
Several Times, Feds Tried to ‘Redirect’ Lab Activities
What if Congress Chooses to Pass an LDT-Specific Law?
How Private Health Insurers May Respond to FDA LDT Regulation
Intelligence
Commentary & Opinion by R. Lewis Dark